Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Fan Chung, Anthony Rowe, Ioannis Pandis, Ratko Djukanovic, Peter Sterk, Yike Guo, Ian Adcock. TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics. Eur Respir J 2016; 48: Suppl. 60, 4900

Member's Comments

No comment yet.

Related content which might interest you: Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects Source: International Congress 2016 – Mechanisms of disease Year: 2016 Asthma Source: Respipedia Article Year: 2018 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Periostin in lower airway samples and serum, a novel asthma marker? Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Aerobic exercise reduces asthma phenotype by inhibition of JAK2, SOCS3 and STAT6 in airway epithelium and in peribronchial leukocytes Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases Year: 2016 Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic Source: Annual Congress 2013 –Asthma Year: 2013 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Activin –A and follistatin in sputum supernatant and BAL in patients with asthma Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014